SCHEMBL25797367

SCHEMBL25797367

CO[P@](=O)(c1ccccc1)c1ccccc1C

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.46
ALDH1A1 P00352 3/20 0.46
MEN1 O00255 6/20 0.43
KMT2A Q03164 6/20 0.43
CA2 P00918 2/20 0.38
POLB P06746 1/20 0.37
LMNA P02545 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CA4 P22748 1/20 0.35
CA5A P35218 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TSHR P16473 2/20 0.35
HTT P42858 1/20 0.35
UTRN P46939 1/20 0.35
ESR1 P03372 1/20 0.34
GAA P10253 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25797365 1.00 L3MBTL1 (0.46) L3MBTL1ALDH1A1MEN1KMT2ACA2
SCHEMBL472001 1.00 L3MBTL1 (0.46) L3MBTL1ALDH1A1MEN1KMT2ACA2
SCHEMBL28688636 0.98 ALDH1A1 (0.44) L3MBTL1ALDH1A1MEN1KMT2ACA2
SCHEMBL3883782 0.88 TSHR (0.39) L3MBTL1ALDH1A1MEN1KMT2ACA2
SCHEMBL23658870 0.82 ALDH1A1 (0.41) L3MBTL1ALDH1A1MEN1KMT2APOLB
SCHEMBL25797370 0.82 ALDH1A1 (0.41) L3MBTL1ALDH1A1MEN1KMT2APOLB
SCHEMBL332078 0.81 L3MBTL1 (0.58) L3MBTL1ALDH1A1MEN1KMT2ACA2
SCHEMBL29468625 0.79 L3MBTL1 (0.44) L3MBTL1ALDH1A1MEN1KMT2ACA2
SCHEMBL18486552 0.79 ALDH1A1 (0.44) L3MBTL1ALDH1A1MEN1KMT2ACA2
SCHEMBL23658867 0.79 KMT2A (0.57) L3MBTL1ALDH1A1MEN1KMT2ACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212204-A1 REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS THE SCRIPPS RESEARCH INSTITUTE 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212204-A1 REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS PNKP, POLL, RNGTT L3MBTL1 1222/4885ALDH1A1 3938/4885MEN1 2014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.